Inactive Instrument
Irwin Naturals Inc. Stock Canadian Securities Exchange
Stocks
IWIN
CA46414Q1054
Pharmaceuticals
OTC Markets Traded| Market Cap | 483K 416K 390K 356K 671K 46.16M 673K 4.63M 1.81M 23.3M 1.81M 1.77M 77.27M | P/E 2021 |
105x | P/E 2022 | -0.91x |
|---|---|---|---|---|---|
| Enterprise Value | 21.01M 18.11M 16.98M 15.5M 29.19M 2.01B 29.29M 201M 78.58M 1.01B 78.89M 77.17M 3.36B | EV / Sales 2021 |
0.13x | EV / Sales 2022 | 0.31x |
| Free-Float |
1.04% | Yield 2021 * |
-
| Yield 2022 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
Klee Irwin
CEO | Chief Executive Officer | 60 | 01/01/1994 |
Mark Green
DFI | Director of Finance/CFO | - | 08/03/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Klee Irwin
CHM | Chairman | 60 | 01/01/1994 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 16/08/21 | Other | Chief Executive Officer | 0 | - | ||
| 16/08/21 | Other | Chief Executive Officer | 0 | - | ||
| 16/08/21 | Marche | Chief Executive Officer | 18,240 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | +46.34% | - | - | 708K | |
| -0.13% | -6.44% | +60.34% | +112.06% | 1,047B | |
| +0.85% | -0.81% | +51.29% | +63.13% | 646B | |
| -1.03% | -3.58% | +21.43% | +73.10% | 451B | |
| -1.46% | -4.50% | +37.80% | +37.41% | 355B | |
| -0.72% | -2.89% | +22.32% | +36.62% | 291B | |
| -1.19% | -2.21% | +1.53% | +10.79% | 252B | |
| -1.05% | -1.57% | +50.30% | +66.55% | 234B | |
| +0.08% | -1.78% | -17.64% | -54.36% | 203B | |
| -2.14% | -0.30% | +28.95% | +86.27% | 181B | |
| Average | -0.68% | -2.68% | +28.48% | +47.95% | 406.59B | |
| Weighted average by Cap. | -0.46% | -3.46% | +38.17% | +65.00% |
| 2021 | 2022 | |
|---|---|---|
| Net sales | 100M 86.46M 81.07M 74M 139M 9.59B 140M 962M 375M 4.84B 377M 369M 16.05B | 89.47M 77.1M 72.29M 65.99M 124M 8.55B 125M 858M 335M 4.32B 336M 329M 14.31B |
| Net income | 8.62M 7.42M 6.96M 6.35M 11.97M 823M 12.01M 82.58M 32.22M 416M 32.35M 31.64M 1.38B | -3.99M -3.44M -3.23M -2.94M -5.55M -382M -5.56M -38.27M -14.93M -193M -14.99M -14.66M -639M |
| Net Debt | 9.35M 8.06M 7.56M 6.9M 12.99M 894M 13.04M 89.65M 34.98M 451M 35.12M 34.35M 1.5B | 20.53M 17.69M 16.59M 15.14M 28.52M 1.96B 28.61M 197M 76.77M 990M 77.07M 75.4M 3.28B |
Employees
-
Sector
Pharmaceuticals
